Clinical trial
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the…
NCT00082719 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00082719 |
|---|---|
| Title | Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium |
| Official title | Modulation of Death Effector Expression By Short-Term Exposure to Low-Dose Interferon |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Urethral Cancer |
| Intervention type | Biological |
| Interventions | Recombinant Interferon Alfa |
| Enrollment | 33 |
| Start date | Dec 1, 2003 |
| Primary completion | Jan 1, 2015 |
| Completion | Jan 1, 2015 |
| First posted | May 19, 2004 |
| Last update posted | May 14, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: